Some previous studies have reported that ERCC1 expression is a predictive factor for survival after chemotherapy in advanced non-small cell lung cancer[27], bladder cancer[28], gastric cancer[24]. This evidence concerns the gene ERCC1 and non-small cell lung carcinoma.